Bigfoot Biomedical

Overview

Bigfoot Biomedical is a company focused on developing innovative solutions for diabetes management. The company aims to simplify and improve the lives of people with insulin-requiring diabetes through the use of advanced technology and data-driven insights.

History

Bigfoot Biomedical was founded in 2014 by Jeffrey Brewer, Lane Desborough, and Bryan Mazlish. The founders were motivated by personal experiences with diabetes and a desire to create more effective and user-friendly tools for managing the condition. The company is headquartered in Milpitas, California.

Products

Bigfoot Biomedical is known for its development of the Bigfoot Unity Diabetes Management System. This system integrates continuous glucose monitoring (CGM) with insulin delivery to provide a comprehensive solution for diabetes management. The system is designed to simplify the process of insulin dosing and improve glycemic control for users.

Bigfoot Unity System

The Bigfoot Unity System includes a smart insulin pen cap that works with disposable insulin pens. It uses data from a connected CGM to provide insulin dose recommendations directly on the pen cap's display. This system is intended to reduce the burden of diabetes management by providing real-time, actionable insights.

Technology

Bigfoot Biomedical leverages advanced technology to create its diabetes management solutions. The company's approach involves integrating hardware, software, and data analytics to provide a seamless user experience. The use of machine learning and artificial intelligence is central to the company's strategy, enabling personalized and adaptive insulin dosing recommendations.

Partnerships

Bigfoot Biomedical has established partnerships with various organizations to enhance its product offerings and expand its reach. Notable partnerships include collaborations with Abbott Laboratories for the integration of the FreeStyle Libre CGM technology into Bigfoot's systems.

Future Developments

Bigfoot Biomedical continues to innovate in the field of diabetes management. The company is focused on expanding its product line and improving the functionality of its existing systems. Future developments may include enhancements to the Bigfoot Unity System and the introduction of new technologies to further simplify diabetes care.

See Also

• Diabetes management
• Continuous glucose monitor
• Insulin therapy